Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Pooled Analysis of Eight Clinical Studies Suggests a Link Between Influenza-Like Symptoms and Pharmacodynamics of the Toll-Like Receptor-7 Agonist Vesatolimod.
Riddler SA, Benson CA, Brinson C, Deeks SG, DeJesus E, Mills A, Para MF, Ramgopal MN, Cai Y, Zheng Y, Zhang L, Jiang W, Liu X, Verrill D, Lim D, de Vries CR, Wallin JJ, Vendrame E, SenGupta D. Riddler SA, et al. Among authors: dejesus e. Infect Dis Ther. 2024 Nov;13(11):2285-2299. doi: 10.1007/s40121-024-01034-w. Epub 2024 Sep 15. Infect Dis Ther. 2024. PMID: 39278975 Free PMC article.
HIV rebound in HIV controllers is associated with a specific fecal microbiome profile.
Cai Y, Podlaha O, Deeks SG, Brinson C, Ramgopal MN, DeJesus E, Mills A, Shalit P, Abdel-Mohsen M, Zhang L, de Vries CR, Vendrame E, SenGupta D, Wallin JJ. Cai Y, et al. Among authors: dejesus e. Eur J Immunol. 2024 Aug;54(8):e2350809. doi: 10.1002/eji.202350809. Epub 2024 May 10. Eur J Immunol. 2024. PMID: 38727191
Efficacy, Safety, and Tolerability of Switching From Bictegravir/Emtricitabine/Tenofovir Alafenamide to Dolutegravir/Lamivudine Among Adults With Virologically Suppressed HIV: The DYAD Study.
Rolle CP, Castano J, Nguyen V, Hinestrosa F, DeJesus E. Rolle CP, et al. Among authors: dejesus e. Open Forum Infect Dis. 2024 Sep 26;11(10):ofae560. doi: 10.1093/ofid/ofae560. eCollection 2024 Oct. Open Forum Infect Dis. 2024. PMID: 39416993 Free PMC article. Clinical Trial.
Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trial.
Julg B, Walker-Sperling VEK, Wagh K, Aid M, Stephenson KE, Zash R, Liu J, Nkolola JP, Hoyt A, Castro M, Serebryannyy L, Yanosick K, Speidel T, Borducchi EN, Murzda T, Maxfield L, Arduino R, McDermott AB, Gama L, Giorgi EE, Koup RA, Seaman MS, Rolle CP, DeJesus E, Li W, Korber B, Barouch DH. Julg B, et al. Among authors: dejesus e. Nat Med. 2024 Dec;30(12):3534-3543. doi: 10.1038/s41591-024-03247-5. Epub 2024 Sep 12. Nat Med. 2024. PMID: 39266747 Free PMC article. Clinical Trial.
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.
Evering TH, Moser C, Jilg N, Ritz J, Wohl DA, Li JZ, Margolis D, Javan AC, Eron JJ, Currier JS, Daar ES, Smith DM, Hughes MD, Chew KW; ACTIV-2/A5401 Study Team. Evering TH, et al. EClinicalMedicine. 2024 Aug 16;75:102787. doi: 10.1016/j.eclinm.2024.102787. eCollection 2024 Sep. EClinicalMedicine. 2024. PMID: 39252866 Free PMC article.
Pavement ant extract is a chemotaxis repellent for C. elegans.
Lopez JS, Ali S, Asher M, Benjamin CA, Brennan RT, Burke MLT, Civantos JM, DeJesus EA, Geller A, Guo MY, Haase Cox SK, Johannsen JM, Kang JSJ, Konsker HB, Liu BC, Oakes KG, Park HI, Perez DR, Sajjadian AM, Torio Salem M, Sato J, Zeng AI, Juarez BH, Gonzalez M, Morales G, Bradon N, Fiocca K, Pamplona Barbosa MM, O'Connell LA. Lopez JS, et al. Among authors: dejesus ea. MicroPubl Biol. 2024 Mar 25;2024:10.17912/micropub.biology.001146. doi: 10.17912/micropub.biology.001146. eCollection 2024. MicroPubl Biol. 2024. PMID: 38596360 Free PMC article.
Actívatexto: Feasibility and Acceptability of a Mobile Intervention That Promotes Smoking Cessation and Physical Activity among Latinos.
Lara D, Alaniz-Cantú EI, Siddalingaiaha S, Oliveira I, Chávez-Iñiguez A, DeJesus E, Fuller D, Marquez DX, Vásquez E, Li D, McIntosh S, Ossip DJ, Cupertino AP, Cartujano-Barrera F. Lara D, et al. Among authors: dejesus e. Cancer Res Commun. 2024 Apr 8;4(4):1016-1023. doi: 10.1158/2767-9764.CRC-23-0519. Cancer Res Commun. 2024. PMID: 38592449 Free PMC article.
284 results